In immunophenotyping for minimal residual disease (MRD) in B-ALL, which combination is most commonly used to identify residual leukemic B-lymphoblasts?
-
A
CD19+/CD10+/TdT+/CD34+ with aberrant markers
-
B
CD20+/CD5+/CD23+ with dim sIg
-
C
CD38+/CD138+/CD56+ lacking CD19
-
D
CD3+/CD4+/CD8+ with high TdT